Kringle Pharma, Inc design mark 50024667
"Design mark 50024667" is a figurative mark owned by Kringle Pharma, Inc., filed at the USPTO on July 31, 2026. It is under examination and covers classes 5 and 42.
- Status
- Under examination
- Since July 31, 2026
- Filed
- July 31, 2026
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 50024667
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Figurative mark
- 2 classes
Who owns Kringle Pharma, Inc design mark 50024667
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Kringle Pharma, Inc.
Osaka-shi, Osaka, Japan
Representative
Kumiko Ide
Wenderoth, Lind & Ponack, LLP
What the mark covers
The products and services Kringle Pharma, Inc design mark 50024667 is filed for, grouped by Nice class.
Pharmaceutical and veterinary preparations for the treatment of liver diseases, renal disease, nerve system diseases, skin diseases, cardiovascular diseases, cancer; pharmaceutical preparations acting on the peripheral nervous system; cardiovascular treatment preparations; capillary stabilizers, namely, pharmaceutical preparations for stabilizing capillaries; cerebral hemorrhage prophylactic preparations; pharmaceutical preparations acting on respiratory organs for treating respiratory illnesses and conditions; pharmaceutical preparations acting on digestive organs for treating ulcers and digestive conditions; pharmaceutical preparations for dental purposes for treating and preventing gingivostomatitis, alveolar abscess, and alveoloclasia; pharmaceutical preparations acting on uro-genital and anal organs for treating urinary and anal gland related illnesses and conditions; medicated skin care preparations; astringents for medical purposes; anti-inflammatory agents; saccharide preparations for treating skin diseases, namely, skin ulcer, injury, burn, scleroderma, dematitis, erythroderma, keratosis, dyschromatosis, and lupus erhthematosus; hemostatics for medical purposes; pharmaceutical preparations affecting metabolism; pharmaceutical preparations for activating cellular function; pharmaceutical preparations for treating physically caused lesions; radiation sickness treating drugs; pharmaceutical preparations for treating chemically caused disorders, namely, for treating chemical burns, side effects of anticancer drugs, and side effects of immunosuppresants; biological preparations for medical purposes, namely, biological tissue grafts
Testing, inspection or research of pharmaceuticals and genetics; medical research; consultancy and providing testing, inspection and research information services in the field of testing, inspection or research of pharmaceuticals and genetics; consultancy and providing research information services in the field of medical research; providing medical research and scientific research information and advice in the fields of pharmaceuticals and genetics
What has happened so far
Steps recorded by the USPTO, newest first.
- Teas amendment entered before attorney assigned
- Teas voluntary amendment received
- Application filing receipt mailed
- New application entered
About Kringle Pharma, Inc design mark 50024667
Who owns the trademark "Design mark 50024667"?
The USPTO trademark "Design mark 50024667" (application 50024667) is owned by Kringle Pharma, Inc.
What is the status of "Design mark 50024667"?
Its status at the USPTO is: under examination.
Get this data via the API
Everything on this page comes from the Signa API. Pull Kringle Pharma, Inc design mark 50024667 and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019fbd6d-754e-710f-83d2-3cf3fdc9732b
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019fbd6d-754e-710f-83d2-3cf3fdc9732b",
"object": "trademark",
"mark_text": "[Design Mark]",
"status": {
"primary": "pending",
"stage": "examining"
},
"office_code": "US",
"application_number": "50024667",
"filing_date": "2026-07-31",
"nice_classes": [
5,
42
],
"owners": [
{
"name": "KRINGLE PHARMA, INC.",
"entity_id": "ent_019eb7be-ee75-719d-83c9-7908297e9223"
}
]
}